First interventional exchange of a left transvenous phrenic nerve stimulation lead from the novel remedē system

4Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

The remedē system is a novel fully implantable transvenous phrenic nerve stimulation (TPNS) device developed to treat central sleep apnea. No information is published on how to explant or replace its leads. An eighty-one year-old had a fractured lead and we removed it over a wire. However, unbreachable resistances occurred with a new lead deployed over the enclosed wire and interventional endovascular techniques were performed to reimplant a new fully functioning system. This first report demonstrates TPNS lead exchange is possible but can be challenging. Interventional maneuvers and techniques, including balloon angioplasty, can facilitate this procedure.

Cite

CITATION STYLE

APA

Gutleben, K. J., Eitz, T., Westlund, R., Gummert, J. F., Sommer, P., & Fox, H. (2020). First interventional exchange of a left transvenous phrenic nerve stimulation lead from the novel remedē system. Journal of Cardiovascular Electrophysiology, 31(11), 3056–3060. https://doi.org/10.1111/jce.14725

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free